[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

EP2001495A4 - Methods for regulating neurotransmitter systems by inducing counteradaptations - Google Patents

Methods for regulating neurotransmitter systems by inducing counteradaptations

Info

Publication number
EP2001495A4
EP2001495A4 EP07751698A EP07751698A EP2001495A4 EP 2001495 A4 EP2001495 A4 EP 2001495A4 EP 07751698 A EP07751698 A EP 07751698A EP 07751698 A EP07751698 A EP 07751698A EP 2001495 A4 EP2001495 A4 EP 2001495A4
Authority
EP
European Patent Office
Prior art keywords
methods
neurotransmitter systems
regulating neurotransmitter
counteradaptations
inducing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07751698A
Other languages
German (de)
French (fr)
Other versions
EP2001495A2 (en
Inventor
Alexander Michalow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP2001495A2 publication Critical patent/EP2001495A2/en
Publication of EP2001495A4 publication Critical patent/EP2001495A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP07751698A 2006-02-27 2007-02-27 Methods for regulating neurotransmitter systems by inducing counteradaptations Withdrawn EP2001495A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US77719006P 2006-02-27 2006-02-27
US85818606P 2006-11-09 2006-11-09
PCT/US2007/004959 WO2007100775A2 (en) 2006-02-27 2007-02-27 Methods for regulating neurotransmitter systems by inducing counteradaptations

Publications (2)

Publication Number Publication Date
EP2001495A2 EP2001495A2 (en) 2008-12-17
EP2001495A4 true EP2001495A4 (en) 2010-12-08

Family

ID=38459618

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07751698A Withdrawn EP2001495A4 (en) 2006-02-27 2007-02-27 Methods for regulating neurotransmitter systems by inducing counteradaptations

Country Status (5)

Country Link
EP (1) EP2001495A4 (en)
JP (1) JP2009528289A (en)
AU (1) AU2007221135A1 (en)
CA (1) CA2643802A1 (en)
WO (1) WO2007100775A2 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002527378A (en) 1998-10-15 2002-08-27 インペリアル・カレッジ・イノベイションズ・リミテッド Method of treatment
AU2006311458C1 (en) 2005-11-10 2013-05-09 Board Of Supervisors Of Louisiana State University & Agricultural & Mechanical College Compositions and methods for the treatment of addiction and other neuropsychiatric disorders
GB0624282D0 (en) 2006-12-05 2007-01-10 Cavalla David Treatment of cachexia
CA2691220C (en) 2007-06-22 2015-05-05 Toray Industries, Inc. Remedy or preventive for integration dysfunction syndrome
WO2009109001A1 (en) * 2008-03-04 2009-09-11 Adelaide Research & Innovation Pty Ltd Method for preventing and/or treating a disease, condition or state associated with reduced dopaminergic neuron function
WO2010074753A1 (en) 2008-12-23 2010-07-01 Map Pharmaceuticals, Inc. Inhalation devices and related methods for administration of sedative hypnotic compounds
WO2011087755A2 (en) 2009-12-22 2011-07-21 Pondera Biotechnologies, LLC Methods and compositions for treating distress dysfunction and enhancing safety and efficacy of specific medications
EP2582375A4 (en) 2010-06-16 2013-12-25 Embera Neurotherapeutics Inc Compositions and methods for the treatment of addiction, psychiatric disorders, and neurodegenerative disease
US11000505B2 (en) * 2010-06-29 2021-05-11 The Trustees Of The University Of Pennsylvania Salvinorin compositions and uses thereof
US10973800B2 (en) * 2010-06-29 2021-04-13 The Trustees Of The University Of Pennsylvania Salvinorin compositions and uses thereof
LT2925757T (en) 2012-11-19 2017-12-27 Novartis Ag Compounds and compositions for the treatment of parasitic diseases
US8871754B2 (en) 2012-11-19 2014-10-28 Irm Llc Compounds and compositions for the treatment of parasitic diseases
US20150352100A1 (en) * 2013-01-21 2015-12-10 Avant Derma Pte. Ltd. Use of selective delta-opioid receptor antagonists and specific sensory receptor ligands
AU2014209107B2 (en) * 2013-01-28 2018-04-12 Viamet Pharmaceuticals (NC), Inc. Metalloenzyme inhibitor compounds
CN104955483A (en) 2013-01-30 2015-09-30 法莫斯医疗公司 Treatments for depression and other diseases with a low dose agent
CA2909504C (en) * 2013-04-17 2021-04-20 H. Lundbeck A/S Nalmefene for treatment of patients with mood disorder
EP3054935B1 (en) 2013-10-07 2020-12-09 Teikoku Pharma USA, Inc. Methods and compositions for treating attention deficit hyperactivity disorder, anxiety and insomnia using dexmedetomidine transdermal compositions
WO2015054058A1 (en) 2013-10-07 2015-04-16 Teikoku Pharma Usa, Inc. Dexmedetomidine Transdermal Delivery Devices and Methods for Using the Same
JP6188933B2 (en) 2013-10-07 2017-08-30 テイコク ファーマ ユーエスエー インコーポレーテッド Methods and compositions for transdermal delivery of non-sedating amounts of dexmedetomidine
WO2016195723A1 (en) * 2015-06-03 2016-12-08 Beller Pharmaceuticals LLC Methods of treatment for conditions mediated by substance p
CN106008487B (en) 2015-12-31 2019-08-09 北京理工大学 A kind of talan analog derivative and preparation method thereof
US11690847B2 (en) 2016-11-30 2023-07-04 Case Western Reserve University Combinations of 15-PGDH inhibitors with corticosteroids and/or TNF inhibitors and uses thereof
JP2020514323A (en) 2017-02-06 2020-05-21 ケース ウエスタン リザーブ ユニバーシティ Compositions and methods for modulating short chain dehydrogenase activity
AU2018230521B2 (en) 2017-03-10 2022-02-03 Embera Neurotherapeutics, Inc. Pharmaceutical compositions and uses thereof
US10729693B2 (en) * 2018-03-02 2020-08-04 Ponce Medical School Foundation, Inc. Compositions and methods for the treatment of endometriosis

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002005749A2 (en) * 2000-07-19 2002-01-24 Bristol-Myers Squibb Pharma Company Crf2 ligands in combination therapy
US20030232827A1 (en) * 2002-02-08 2003-12-18 Meltzer Peter C. Therapeutic compounds
WO2006034343A2 (en) * 2004-09-23 2006-03-30 Alexander Michalow methods for regulating neurotransmitter systems by inducing counteradaptationS

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP150098A0 (en) * 1998-01-27 1998-02-19 Fujisawa Pharmaceutical Co., Ltd. Benzamide derivatives
TWI256309B (en) * 1999-10-13 2006-06-11 Akzo Nobel Nv New formulation of mirtazapine
US6437093B1 (en) * 2000-11-28 2002-08-20 Milkhaus Laboratory, Inc. Methods of treatment comprising administration of Substance P

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002005749A2 (en) * 2000-07-19 2002-01-24 Bristol-Myers Squibb Pharma Company Crf2 ligands in combination therapy
US20030232827A1 (en) * 2002-02-08 2003-12-18 Meltzer Peter C. Therapeutic compounds
WO2006034343A2 (en) * 2004-09-23 2006-03-30 Alexander Michalow methods for regulating neurotransmitter systems by inducing counteradaptationS

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ABDOLLAHIAN E ET AL: "Effects of desmopressin (DDAVP) on memory impairment following electroconvulsive therapy (ECT)", June 2004, ACTA NEUROPSYCHIATRICA 200406 GB LNKD- DOI:10.1111/J.0924-2708.2004.00064.X, VOL. 16, NR. 3, PAGE(S) 130 - 137, ISSN: 0924-2708, XP002605346 *
DINAN TIMOTHY G ET AL: "Desmopressin normalizes the blunted adrenocorticotropin response to corticotropin-releasing hormone in melancholic depression: Evidence on enhanced vasopressinergic responsivity", June 1999, JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, VOL. 84, NR. 6, PAGE(S) 2238-2240, ISSN: 0021-972X, XP002605345 *

Also Published As

Publication number Publication date
WO2007100775A2 (en) 2007-09-07
JP2009528289A (en) 2009-08-06
EP2001495A2 (en) 2008-12-17
WO2007100775A3 (en) 2008-11-27
CA2643802A1 (en) 2007-09-07
AU2007221135A1 (en) 2007-09-07

Similar Documents

Publication Publication Date Title
EP2001495A4 (en) Methods for regulating neurotransmitter systems by inducing counteradaptations
EP1809104A4 (en) Methods for regulating neurotransmitter systems by inducing counteradaptations
GB2440766B (en) Control system
PL2147576T3 (en) System for controlling light sources
PL3812870T3 (en) Flow control system
ZA201001753B (en) Method for consumer-dispenser interactions
IL193650A0 (en) Rate control for multi-channel commuinication systems
EG25449A (en) Anti-bogdown control system for turbine/compressorsystems
GB0609312D0 (en) Clearance Control Apparatus
EP2283220A4 (en) Apparatus for engine control
GB2452680B (en) Device for regulating pressure
GB2448278B (en) System for accepting value from closed groups
SG10201501328WA (en) Controlled ambient system for interface engineering
GB2450342B (en) Control System
PT2385634E (en) System for emergency rate adjustment
ZA201002402B (en) Control system
ZA200906644B (en) Control device for lubrication systems
EP2252376A4 (en) Control system for uv-pco air purifier
TWI350481B (en) System for automatically preloading software elements
GB0705929D0 (en) E-springs for suspension systems
EP2022666A4 (en) Circular regulation system
TWI341435B (en) Optical system for projecting
GB2455886B (en) Control system
GB2437387B (en) Fuel control system
GB2439655B (en) Control system

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20080926

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

R17D Deferred search report published (corrected)

Effective date: 20081127

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/00 20060101ALI20101026BHEP

Ipc: A61P 25/00 20060101ALI20101026BHEP

Ipc: A61P 25/24 20060101ALI20101026BHEP

Ipc: A61P 25/22 20060101ALI20101026BHEP

Ipc: A61K 38/00 20060101AFI20081112BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20101105

17Q First examination report despatched

Effective date: 20110819

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20111230